Graphics credits: COMPARTMENTS | More Info
Parameter | Value |
---|---|
Gene | NOS3 |
Protein Name | NOS3_HUMAN |
Organism | Homo sapiens (Human) |
Alternative name(s) | Nitric oxide synthase, endothelial (EC 1.14.13.39) (Constitutive NOS) (cNOS) (EC-NOS) (Endothelial NOS) (eNOS) (NOS type III) (NOSIII) |
Protein Family | NOS family |
NCBI Gene ID | 4846 |
UniProt ID | P29474 |
Enzyme Class | 1.14.13.39 |
Molecular Weight | 133275 |
Protein Length | 1203 |
Protein Domain | InterPro | Pfam |
3D Structure |
PDBe |
PDBj |
RCSB PDB |
DrugPort
ModBase | SwissModel |
Gene Expression | Gene Expression Atlas |
Function and Disease | OMIM |
Protein-protein Interaction Database | STRING | IntAct | MINT |
Kinase Database | Phospho.ELM | PhosphoSite | NetworKIN |
Catalytic Activity (UniProt annotation) | 2 L-arginine + 3 NADPH + 4 O(2) = 2 L-citrulline + 2 nitric oxide + 3 NADP(+) + 4 H(2)O. |
Localization | Cell membrane. Membrane, caveola. Cytoplasm, cytoskeleton. Golgi apparatus. Note=Specifically associates with actin cytoskeleton in the G2 phase of the cell cycle; which is favored by interaction with NOSIP and results in a reduced enzymatic activity. |
Function (UniProt annotation) | Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets.; Isoform eNOS13C: Lacks eNOS activity, dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1. |
Gene Ontology | GO:0000139; GO:0001525; GO:0001542; GO:0001701; GO:0001974; GO:0002028; GO:0003057; GO:0003100; GO:0003180; GO:0003184; GO:0003203; GO:0003785; GO:0003958; GO:0004517; GO:0005516; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0006527; GO:0006809; GO:0007005; GO:0007263; GO:0008217; GO:0008285; GO:0009408; GO:0009725; GO:0010181; GO:0010544; GO:0010628; GO:0012506; GO:0014740; GO:0014806; GO:0016491; GO:0019430; GO:0020037; GO:0030324; GO:0030666; GO:0031284; GO:0031663; GO:0032496; GO:0034405; GO:0034617; GO:0034618; GO:0042311; GO:0043267; GO:0043536; GO:0043542; GO:0045454; GO:0045766; GO:0045776; GO:0046870; GO:0048873; GO:0050660; GO:0050661; GO:0050880; GO:0050999; GO:0051186; GO:0051346; GO:0051926; GO:0060412; GO:0070168; GO:0097110; GO:1902042 |
Gene Name | Organism | P-Site | Sequence(+/-7) | Conservation | Disorder | Curator Assessment | Reliability | Evidence Class | Evidence Logic | PubMed | Phospho-ELM | PhosphoSite-Plus |
---|---|---|---|---|---|---|---|---|---|---|---|---|
PRKAA1 (Q13131) | Homo sapiens | S1177 | TSRIRTQSFSLQERQ | 0.14 | 0.4409 | TP | certain | experimental | 72 | 55 | | 16126727 | - |
|
Prkaa2 (Q09137) | Rattus norvegicus | S1177 | TSRIRTQSFSLQERQ | 0.14 | 0.4409 | TP | certain | experimental | 30 | 55 | 23 | 135 | | 10025949 | - |
|
Prkaa1 (P54645) | Rattus norvegicus | S1177 | TSRIRTQSFSLQERQ | 0.14 | 0.4409 | TP | certain | experimental | 30 | 55 | 23 | 135 | | 10025949 | - |
|
Prkaa2 (Q09137) | Rattus norvegicus | T495 | TGITRKKTFKEVANA | 0.231 | 0.3087 | TP | certain | experimental | 30 | 55 | 23 | 135 | | 10025949 | - |
|
Prkaa1 (P54645) | Rattus norvegicus | T495 | TGITRKKTFKEVANA | 0.231 | 0.3087 | TP | certain | experimental | 30 | 55 | 23 | 135 | | 10025949 | - |
|
PRKAA1 (Q13131) | Homo sapiens | S633 | WRRKRKESSNTDSAG | 0.163 | 0.4801 | - | - | - | - | - | - |
|
PRKAA2 (P54646) | Homo sapiens | S1177 | TSRIRTQSFSLQERQ | 0.14 | 0.4409 | - | - | - | - | - | - |
|
PRKAA2 (P54646) | Homo sapiens | S633 | WRRKRKESSNTDSAG | 0.163 | 0.4801 | - | - | - | - | - | - |
|
Reactome Pathways
KEGG Pathways
NCI Nature PID Pathways